Apriori Bio
22 employees on LinkedIn · 3 known investors
Find your way into Apriori Bio
Sign up to see every warm intro you have to Apriori Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Apriori Bio team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Apriori Bio applies AI/ML combined with biological insights to predict how viruses evolve and to design vaccines, assessing their expected performance before clinical trials. The company operates in the vaccinology and biotech space.
Investors · 3
Also in the syndicate · 1
CEPI
Funding
SEC filings, press & company announcements$1.1M disclosed across 1 round · 2024
- $1.1MraisedJul 2024 · 2 sources
CEPI
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through Apriori Bio went on to found or lead other companies.
In the news
Frequently asked questions
- What does Apriori Bio do?
- Apriori Bio applies AI/ML combined with biological insights to predict how viruses evolve and to design vaccines, assessing their expected performance before clinical trials. The company operates in the vaccinology and biotech space.
- Who are Apriori Bio's investors?
- Apriori Bio's investors include Flagship Pioneering, Global Health Investment Corporation.
- How much funding has Apriori Bio raised?
- Apriori Bio has disclosed $1.1M raised across 1 round.




